VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma.

VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma. Oncotarget. 2017 Oct 24;8(51):88257-88258 Authors: Ruggiero C, Lalli E PMID: 29179432 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research